Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

Autor: Lekuona, Iñaki, Anguita, Manuel, Zamorano, José Luis, Rodríguez, José Manuel, Barja de Soroa, Paloma, Pérez-Alcántara, Ferran
Zdroj: In Revista Española de Cardiología (English Edition) May 2019 72(5):398-406
Databáze: ScienceDirect